• Je něco špatně v tomto záznamu ?

Non-invasive assessment of vascular system function and damage induced by anthracycline treatment in the pediatric cancer survivors

K. Budinskaya, V. Puchnerová, J. Svačinová, J. Novák, H. Hrstková, M. Nováková, A. Pekařová, M. Pekař, Z. Nováková

. 2017 ; 66 (Supplementum 4) : S553-S560. [pub] 2017Dec30
. 2017 ; () : S553-S560.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19030480

Anthracyclines represent one of the important classes of anti-cancer drugs; however, their major disadvantage is their profound cardiovascular toxicity. This study aimed to evaluate influence of anthracyclines on cardiovascular stiffness parameters estimated from pulse wave (PW). PW was measured in 59 cancer survivors treated with anthracyclines in childhood and in 248 healthy age-matched controls. Both patients and controls were divided into three age groups (13 - 15, 16 - 18 and 19 - 24 years). Central PW augmentation index (C-AI75) and augmentation pressure (C-AP75), both normalized to heart rate 75 bpm, were calculated as parameters of arterial wall stiffness. Central Buckberg sub-endocardial viability ratio (SEVR) was calculated as a parameter of diastolic function. Patients and controls were compared in each age group. C-AI75 and C-AP75 were significantly increased in patients in age groups 16 - 18 and 19 - 24 years. SEVR was decreased in patients in the oldest age group. Our results suggest that although toxic influence of anthracyclines to arterial wall and heart are developing during childhood and puberty, they can be detected rather in the adulthood. These changes are yet subclinical; however, their presence indicates potentially increased cardiovascular risk in childhood cancer survivors treated with anthracyclines during childhood.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19030480
003      
CZ-PrNML
005      
20200309151824.0
007      
ta
008      
190830s2017 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933794 $2 doi
035    __
$a (PubMed)29355384
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Budinskaya, K. $7 _AN102629 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Non-invasive assessment of vascular system function and damage induced by anthracycline treatment in the pediatric cancer survivors / $c K. Budinskaya, V. Puchnerová, J. Svačinová, J. Novák, H. Hrstková, M. Nováková, A. Pekařová, M. Pekař, Z. Nováková
520    9_
$a Anthracyclines represent one of the important classes of anti-cancer drugs; however, their major disadvantage is their profound cardiovascular toxicity. This study aimed to evaluate influence of anthracyclines on cardiovascular stiffness parameters estimated from pulse wave (PW). PW was measured in 59 cancer survivors treated with anthracyclines in childhood and in 248 healthy age-matched controls. Both patients and controls were divided into three age groups (13 - 15, 16 - 18 and 19 - 24 years). Central PW augmentation index (C-AI75) and augmentation pressure (C-AP75), both normalized to heart rate 75 bpm, were calculated as parameters of arterial wall stiffness. Central Buckberg sub-endocardial viability ratio (SEVR) was calculated as a parameter of diastolic function. Patients and controls were compared in each age group. C-AI75 and C-AP75 were significantly increased in patients in age groups 16 - 18 and 19 - 24 years. SEVR was decreased in patients in the oldest age group. Our results suggest that although toxic influence of anthracyclines to arterial wall and heart are developing during childhood and puberty, they can be detected rather in the adulthood. These changes are yet subclinical; however, their presence indicates potentially increased cardiovascular risk in childhood cancer survivors treated with anthracyclines during childhood.
650    _2
$a mladiství $7 D000293
650    _2
$a antracykliny $x škodlivé účinky $7 D018943
650    _2
$a antibiotika antitumorózní $x škodlivé účinky $7 D000903
650    _2
$a krevní tlak $x účinky léků $x fyziologie $7 D001794
650    12
$a přežívající onkologičtí pacienti $7 D000073116
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční frekvence $x účinky léků $x fyziologie $7 D006339
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a analýza pulzové vlny $x metody $7 D063177
650    _2
$a výsledek terapie $7 D016896
650    _2
$a nemoci cév $x chemicky indukované $x diagnóza $x patofyziologie $7 D014652
650    _2
$a tuhost cévní stěny $x fyziologie $7 D059289
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Puchnerová, Veronika $7 xx0240401 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Svačinová, Jana $7 xx0240535 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Novák, Jan $7 xx0209446 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Hrstková, Hana, $d 1944- $7 jn20000401084 $u Department of Paediatric Oncology, Faculty of Medicine and Faculty Hospital Brno, Masaryk University, Brno, Czech Republic
700    1_
$a Nováková, Marie, $d 1965- $7 xx0006795 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Pekařová, Anna. $7 xx0240510 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Pekař, Matej $7 xx0240508 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Nováková, Zuzana. $7 mzk2002103492 $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, Supplementum 4 (2017), s. S553-S560
773    0_
$t Proceedings of the ... Physiological days : $g (2017), s. S553-S560 $w MED00183838
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29355384 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190830 $b ABA008
991    __
$a 20200309152242 $b ABA008
999    __
$a ok $b bmc $g 1440117 $s 1068968
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c Supplementum 4 $d S553-S560 $e 2017Dec30 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2017 $d S553-S560 $m Proceedings of the ... Physiological days $x MED00183838
LZP    __
$b NLK118 $a Pubmed-20190830

Najít záznam

Citační ukazatele

Možnosti archivace